Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free INDP Stock Alerts $2.12 -0.03 (-1.40%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Indaptus Therapeutics Short Interest DataCurrent Short Volume25,800 sharesPrevious Short Volume86,200 sharesChange Vs. Previous Month-70.07%Dollar Volume Sold Short$55,986.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares8,540,000 sharesFloat Size5,900,000 sharesShort Percent of Float0.44%Today's Trading Volume2,413 sharesAverage Trading Volume61,888 sharesToday's Volume Vs. Average4% Short Selling Indaptus Therapeutics ? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202425,800 shares $55,986.00 -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228,430.00 -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224,224.00 +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185,878.00 +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73,700.00 +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29,928.00 +18.6%0.3%1.8 $1.74 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202414,500 shares $23,925.00 -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33,855.00 -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36,080.00 -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44,748.00 -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52,432.00 +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42,020.00 +64.7%0.3%1 $2.20 10/31/202311,600 shares $26,448.00 -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30,720.00 -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38,570.00 -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69,290.00 -9.3%0.4%1 $3.38 8/31/202322,600 shares $64,862.00 -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104,608.00 +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44,919.00 +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31,730.00 -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32,470.00 -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46,452.00 -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43,847.00 -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56,160.00 -51.4%0.5%1 $2.08 4/30/202355,600 shares $145,060.40 +159.8%1.0%2 $2.61 4/15/202321,400 shares $41,730.00 -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43,660.00 -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41,040.00 +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45,150.00 -21.3%0.5%1 $1.75 2/15/202332,800 shares $58,712.00 -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69,207.00 +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61,451.00 -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77,865.00 -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195,000.00 +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30,415.71 -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30,276.75 +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30,378.00 +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27,360.00 -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38,448.00 -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61,104.00 -8.1%0.5%0.9 $2.68America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 25,800 shares of INDP short. 0.44% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.44% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 25,800 shares, a decline of 70.1% from the previous total of 86,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 8,540,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 5,900,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 0.44% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Indaptus Therapeutics: Vincerx Pharma, Inc. (5.98%), Minerva Neurosciences, Inc. (0.47%), NeuroSense Therapeutics Ltd. (0.16%), VBI Vaccines Inc. (1.38%), Aytu BioPharma, Inc. (7.15%), Talphera, Inc. (0.90%), Orgenesis Inc. (0.84%), Vaxxinity, Inc. (3.61%), Aptorum Group Limited (0.50%), Tonix Pharmaceuticals Holding Corp. (1.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VINC Short Interest Data NERV Short Interest Data NRSN Short Interest Data VBIV Short Interest Data AYTU Short Interest Data TLPH Short Interest Data ORGS Short Interest Data VAXX Short Interest Data APM Short Interest Data TNXP Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press